The US Chronic Disease Management Market is projected to grow significantly between 2025 and 2034 driven by increasing prevalence of chronic illnesses and rising adoption of digital healthcare technologies. Remote patient monitoring, telehealth platforms, and AI-powered analytics are transforming long-term disease management across the United States. Healthcare providers are adopting advanced monitoring solutions to improve patient outcomes and reduce hospital readmissions. Growing elderly population and value-based healthcare models are further supporting market expansion. The market is expected to reach USD 8.2 billion by 2034 with strong growth throughout the forecast period.

The US Chronic Disease Management Market is projected to reach USD 2.6 billion in 2025, driven by the high and rising prevalence of chronic conditions, an aging population, and a strong shift toward value-based care and digital health integration nationwide. The market is expected to expand at a compound annual growth rate (CAGR) of 13.5% from 2025 to 2034, reaching a projected value of USD 8.2 billion by 2034.

Growth is fueled by the widespread adoption of remote patient monitoring (RPM) and telehealth, strategic integration of artificial intelligence (AI) and predictive analytics, evolving regulatory and reimbursement frameworks (such as CMS guidelines and FDA digital health policies), and increasing demand for cost-effective, patient-centered care models. Furthermore, expanding applications across Diabetes, Cardiovascular Diseases (CVD), and Chronic Respiratory Diseases, alongside the push for interoperable solutions and comprehensive population health management, are expected to significantly accelerate market expansion.

The US chronic care landscape is rapidly transitioning from reactive, episodic care to continuous, data-driven management ecosystems. A pivotal trend is the strategic convergence of disease-specific digital therapeutics and telehealth, where CDM platforms are evolving into integrated care delivery hubs. These hubs enable personalized monitoring, virtual visits, and automated interventions, which are essential for meeting quality metrics and patient self-management goals under value-based reimbursement models.

This integration empowers proactive health management and provides real-time clinical decision support for complex conditions like heart failure and COPD. Concurrently, CDM solution providers are embedding sophisticated analytics and clinical decision support (CDS) tools, offering risk stratification and personalized care pathway automation as core features, making data intelligence central to the chronic care value chain. The fusion of AI with population health platforms is also gaining prominence, optimizing resource allocation and preemptively identifying high-risk patient cohorts across diverse US healthcare settings.